1. Home
  2. BOKF vs HALO Comparison

BOKF vs HALO Comparison

Compare BOKF & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BOK Financial Corporation

BOKF

BOK Financial Corporation

N/A

Current Price

$126.46

Market Cap

7.6B

Sector

Finance

ML Signal

N/A

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$67.92

Market Cap

8.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BOKF
HALO
Founded
1910
1998
Country
United States
United States
Employees
5034
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
8.8B
IPO Year
2007
2001

Fundamental Metrics

Financial Performance
Metric
BOKF
HALO
Price
$126.46
$67.92
Analyst Decision
Hold
Buy
Analyst Count
10
11
Target Price
$127.10
$78.18
AVG Volume (30 Days)
292.4K
1.8M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
2.01%
N/A
EPS Growth
12.65
N/A
EPS
9.17
2.56
Revenue
N/A
$151,862,000.00
Revenue This Year
$6.56
$28.24
Revenue Next Year
$5.35
$12.79
P/E Ratio
$13.67
$26.28
Revenue Growth
N/A
N/A
52 Week Low
$85.08
$47.50
52 Week High
$138.42
$82.22

Technical Indicators

Market Signals
Indicator
BOKF
HALO
Relative Strength Index (RSI) 40.54 37.52
Support Level $103.22 $63.85
Resistance Level $138.25 $68.00
Average True Range (ATR) 3.53 1.94
MACD -0.87 -0.58
Stochastic Oscillator 34.73 21.55

Price Performance

Historical Comparison
BOKF
HALO

About BOKF BOK Financial Corporation

BOK Financial Corp is a financial institution based in Oklahoma that offers a broad range of nationally competitive financial products and services. The company operates through three main segments: Commercial Banking, Consumer Banking, and Wealth Management. Commercial Banking provides lending, treasury and cash management, and risk management services, and includes the TransFund EFT network. Consumer Banking focuses on retail lending, deposit services, and mortgage loan origination and servicing. Wealth Management engages mainly in brokerage and trading activities, particularly in U.S. government agency mortgage-backed securities and related derivatives. The company generates the majority of its revenue from the Commercial Banking segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: